Showing results (251-260 of 4,869) with videos related to

Sort By:
Pageof 487
Urologic Oncology|March 1, 2021
Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinomaMehdi Kardoust Parizi, Vitaly Margulis, Yair Lotan, et al.
Urologic Oncology|May 6, 2014
Urinary nerve growth factor as an oncologic biomarker for prostate cancer aggressivenessMichael A Liss, Adam Gordon, Blanca Morales, et al.
Urologic Oncology|December 10, 2016
The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemesMarco Moschini, Shahrokh F Shariat, Mohammad Abufaraj, et al.
Urologic Oncology|December 14, 2016
Dynamics of three-dimensional telomere profiles of circulating tumor cells in patients with high-risk prostate cancer who are undergoing androgen deprivation and radiation therapiesLandon Wark, Thomas Klonisch, Julius Awe, et al.
Urologic Oncology|March 26, 2017
A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancerNicholas M Donin, Karim Chamie, Andrew T Lenis, et al.
Urologic Oncology|March 27, 2017
Urologic Oncologic SurveyRobotic level III inferior vena cava tumor thrombectomy: Initial series. Gill IS, Metcalfe C, Abreu A, Duddalwar V, Chopra S, Cunningham M, Thangathurai D, Ukimura O, Satkunasivam R, Hung A, Papalia R, Aron M, Desai M, Gallucci M. J Urol. 2015 Oct;194(4):929-938. [Epub 2015 Apr 6]. doi: 10.1016/j.juro.2015.03.119Max Meng
Urologic Oncology|April 1, 2017
Ejaculatory frequency and the risk of aggressive prostate cancer: Findings from a case-control studyNathan P Papa, Robert J MacInnis, Dallas R English, et al.
Urologic Oncology|February 14, 2017
Modified frailty index associated with Clavien-Dindo IV complications in robot-assisted radical prostatectomies: A retrospective studyIsaiah Levy, Mark Finkelstein, Khawaja Hassan Bilal, et al.
Urologic Oncology|February 14, 2017
Role of radical prostatectomy in metastatic prostate cancer: A reviewMichael J Metcalfe, Marc C Smaldone, Daniel W Lin, et al.
Urologic Oncology|February 17, 2017
The metastatic potential of renal tumors: Influence of histologic subtypes on definition of small renal masses, risk stratification, and future active surveillance protocolsMichael Daugherty, Dillon Sedaghatpour, Oleg Shapiro, et al.
Pageof 487